PRESCRIBING SGLT2 INHIBITORS IN ACUTE HEART FAILURE: CONSIDERATIONS FOR DYSGLYCEMIA STATUS, HEART FAILURE PHENOTYPE, AND KIDNEY FUNCTION ArticleMedovchshikov V.V., Yeshniyazov N., Khasanova E., Zholdin B., Kurmanalina G., Kushimova D., Tleumagambetova B., Amanova A., Kobalava Z.European Journal of Heart Failure. Том 26. 2024. С. 591-592
CARDIOVASCULAR DISEASES AND TYPE 2 DIABETES MELLITUS: HIGH HEART FAILURE RISK AND LOW RATE CONTRAINDICATIONS TO SGLT2I ArticleMedovchshikov V.V., Yeshniyazov N., Khasanova E., Zholdin B., Kurmanalina G., Amanova A., Kobalava Z.European Journal of Heart Failure. Том 26. 2024. С. 563-563
SIMILAR INCIDENCE OF OVER AND UNDERDIAGNOSIS OF HEART FAILURE IN HOSPITALIZED PATIENTS WITH TYPE 2 DIABETES MELLITUS ArticleMedovchshikov V., Yeshniyazov N., Khasanova E., Kobalava Z.European Heart Journal. Том 42. 2021. С. 1005-1005
THE LOW FREQUENCY OF CONFORMITY BASELINE LDL-C AND TAKING STATINS IN HOSPITALIZED PATIENTS WITH CVD REGARDLESS OF THE STATUS OF CARBOHYDRATE METABOLISM DISORDERS ArticleMedovchshikov V., Yeshniyazov N., Khasanova E., Bayarsaikhan M., Kobalava Z.Atherosclerosis. Том 331. 2021.
DECREASED INDICES OF MYOCARDIAL WORK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITHOUT SYMPTOMS OF HEART FAILURE ArticleMedovchshikov V., Yeshniyazov N., Khasanova E., Safarova A., Kobalava Z.European Journal of Heart Failure. Том 23. 2021. С. 270-271
EARLY HEART REMODELING IN TYPE 1 DIABETES PATIENTS: POSSIBLE PHENOTYPES ArticleMahamat Y., Safarova A., Kokhan E., Khasanova E., Safarova N., Efimova V., Kobalava Z.European Journal of Heart Failure. Том 21. 2019. С. 361-361